Copyright
©The Author(s) 2023.
World J Gastroenterol. Feb 21, 2023; 29(7): 1173-1193
Published online Feb 21, 2023. doi: 10.3748/wjg.v29.i7.1173
Published online Feb 21, 2023. doi: 10.3748/wjg.v29.i7.1173
Table 1 Endoscopic closure techniques
Endoscopic techniques | Indications/advantages | Not indicated/disadvantages | Authors experience |
Cap-mounted clips | (1) Acute/ early/ late/ chronic; (2) Small orifices (< 20 mm); and (3) Safe | (1) Orifices > 20 mm; (2) Need for external drainage; and (3) Variable efficacy | (1) Acute/ early/ late/ chronic; (2) Safe; (3) < 10 mm: > efficacy; (4) > 10mm: very low efficacy; (5) Combined therapy improves its efficacy; and (6) Can be removed when fails to close the defect (not easy to remove) |
Glues/ tissue sealants | (1) Acute/ early/ late/ chronic; (2) Diameter < 10 mm; (3) Low drainage (< 200 ml/24 h); and (4) Safe | (1) Multiple sessions are usually required; (2) Need for external drainage; and (3) Variable efficacy | (1) Late/ chronic; (2) Low efficacy; (3) Safe; (4) Helpful as an adjunctive therapy; (5) Never use it as a single therapy; (6) Multiple sessions; (7) Cytology brushing or APC is useful to loosen granulation tissue before application; (8) Delivery via endoscopic or percutaneous access; and (9) High cost (tissue sealants) |
Endoscopic suturing | (1) Acute/ early/ late/ chronic; (2) High technical success; and (3) Safe | (1) Need for external drainage; (2) Low efficacy (need for robust and healthy tissue for primary closure); (3) Challenging: Previous experience with the device is needed; and (4) High costs (most countries) | (1) Very poor long-term clinical success; (2) Helpful for other devices fixation; (3) Not recommended for chronic defects; and (4) High cost |
Table 2 Endoscopic covering techniques
Endoscopic techniques | Indications/advantages | Not indicated/disadvantages | Authors experience |
Conventional (esophageal) stents | (1) Acute/ early; (2) Satisfactory efficacy; (3) Very popular; (4) Widely available; (5) International guidelines support; (6) Easy placement; (7) Early oral intake; and (8) Low number of repeated procedures | (1) Late/ chronic; (2) High migration rates; (3) Need for external drainage; (4) Mild symptoms related to the stent; and (5) Possible “surprise” when removing it | (1) Acute/ early; (2) Satisfactory efficacy; (3) Easy placement/ not expensive; (4) Helpful for complete dehiscence; (5) PCSEMS > FCSEMS (challenging removal – do not keep it for > 3 wk); and (6) High migration rates (FCSEMS) |
Bariatric stents | (1) Acute/Early; (2) Satisfactory efficacy; (3) “Perfect” shape for LSG leaks; (4) Low number of repeated procedures ; and (5) Easy placement | (1) Late/ chronic; (2) High migration rates; (3) Need for external drainage; (4) Severe symptoms related to the stent; and (5) Possible “surprise” when removing it | (1) Acute/ early; (2) Similar efficacy to the conventional stent; (3) More expensive than the conventional stent; (4) Helpful for downstream stenosis and complete dehiscence; (5) Pre-pyloric position: more symptoms; (6) Post-pyloric position: more migration; (7) High rates of adverse events (ulcers and perforations); and (8) Intolerance due to symptoms related to the stent (GERD, pain, and emesis) |
Cardiac septal defect occluder | (1) Late/ chronic; (2) High efficacy; (3) Safe; and (4) Epithelialized surface is required for device fixation | (1) Need for external drainage; (2) Off-label use; (3) High cost; and (4) Acute and early: enlargement and migration if no epithelialized surface | (1) Very high efficacy for late/ chronic defects with epithelialized tract without associated collection; (2) Safe; (3) High cost; (4) Off-label; (5) Indicated after conventional techniques failure; and (6) Size selection based on defect size (2:1) |
Table 3 Endoscopic draining techniques
Endoscopic techniques | Indications/advantages | Not indicated/disadvantages | Authors experience |
Endoscopic vacuum therapy | (1) Acute/ early/ late/ chronic; (2) High efficacy in leaks and fistulas with or without associated collection; (3) No need for external drainage; (4) Superior to stent in upper GI tract; and (5) Unique mechanism of action: macro-deformation/ micro-deformation, changes in perfusion/ angiogenesis/exudate control/bacterial clearance | (1) Inability to achieve negative pressure; (2) No endoscopic access; (3) Patient discomfort related to nasogastric tube; (4) Usually repeated procedures are needed (especially when traditional sponge is used); and (5) Longer hospital stay/ high costs (?) | (1) Acute/ early/ late/ chronic; (2) Very high clinical success rates; (3) You must place the EVT system in intracavitary position when an associated collection is identified; (4) Placement of both intracavitary and intraluminal EVT appears to be the best approach; (5) Traditional sponge: challenging placement and removal (mouth), prolonged procedures, and need for multiple exchanges (6) Low-cost modified EVT: easy placement and removal, reduction in procedure time, longer interval between EVT system exchanges, low cost, and low AEs rates; and (7) Modified triple-lumen EVT: drainage and nutrition with one tube through the nares |
Endoscopic internal drainage with double pigtail stent | (1) Acute/early/late/chronic; (2) High efficacy; (3) No need for external drainage; (4) Need of an associated collection; (4) Easy placement (7fr – gastroscope); (5) Small or large orifices; and (6) Short hospital stay | (1) Defects without an associated collection; (2) No place to accommodate the DPS (small collection: < 2 cm); (3) Long period for complete healing; (4) Risk of migration, perforation and bleeding; and (5) Usually, fluoroscopy is needed | (1) Acute/ early/ late/ chronic; (2) High clinical success rates; (3) Small orifices with associated collection; (4) Easy placement; (5) Shorter hospital stay/ electives procedures for DPS exchanges; (6) Faster oral intake (start with clear liquids); (7) Better patient acceptance – no symptoms; (8) Long period for complete healing; and (9) Ureteral stents appear to be safer with similar efficacy |
Septotomy | (1) Early/late/chronic (> 15 d); (2) High efficacy; (3) Safe; (4) Septum between the orifice/ collection and the gastric lumen; and (5) Must do it when a septum is identified | It is only performed when a septum is identified | (1) Early/late/chronic (> 15 d); (2) Very high clinical success; (3) Usually more than 1 session is required; (4) Cut until the staple line; (5) APC or Knife (APC < bleeding); (6) Always dilate after septotomy; (7) Outpatient procedure; and (8) Septum is the cause of most late/chronic refractory defects treated in a center without experience |
Table 4 Suggested recommendations on management of post bariatric surgical leaks and fistulas
Leak or fistula characteristics + patient clinical condition | Recommended management (first line approach) | Possible therapy (second line approach) | Possible endoscopic therapies based on defect characteristics |
Acute and early leaks with undrained uncontained collection in unstable patients | Surgical lavage + external drainage (surgical placement) ± surgical repair ± endoscopic therapy (see column 4) | Image-guided external drainage + endoscopic therapy (see column 4) OR Intracavitary EVT | Defect < 2 cm: Cap mounted clips OR stents OR intraluminal EVT; Defect > 2 cm: Stents OR intraluminal EVT; If a septum is diagnosed (early): Septotomy must be performed |
Acute and early leaks with undrained uncontained collections in stable patients (rare condition as most patients with undrained uncontained collections presents with peritonitis/sepsis) | Image-guided external drainage + endoscopic therapy (see column 4) | Surgical lavage + external drainage (surgical placement) ± surgical repair ± endoscopic therapy (see column 4) OR Intracavitary EVT | Defect < 2 cm: Cap mounted clip OR stents (prefer stents if associated with downstream stenosis) OR intraluminal EVT; Defect > 2 cm: Stents OR intraluminal EVT; If a septum is diagnosed (early): Septotomy must be performed |
Acute and early leaks with undrained contained collections (both unstable or stable patients - most of these patients are stable due to the contained collection) | Endoscopic drainage techniques: Intracavitary EVT OR EID with DPS; If a septum is identified, septotomy must be performed | Image-guided external drainage + endoscopic therapy (see column 4) | Defect < 2 cm: Cap mounted clips OR stents (prefer stents if associate with downstream stenosis) OR intraluminal EVT; Defect > 2 cm: Stents OR intraluminal EVT; If a septum is diagnosed (early): Septotomy must be performed |
Late and chronic leaks (both unstable or stable patients - most of these patients are stable as uncontained collection are extremely rare in late and chronic leaks) | Endoscopic drainage techniques: EID with DPS OREVT (intracavitary if associated collection > 3 cm); If a septum is identified, septotomy must be performed | Image-guided external drainage + endoscopic therapy (see column 4) OR Surgical approach | Defect < 2 cm: Cap mounted clips OR CSDO OR tissue sealants/glues (as an adjunctive therapy); Defect > 2 cm: CSDO OR tissue sealants/glues (as an adjunctive therapy) |
Late and chronic fistulas (both unstable or stable patients - most of these patients are stable) | Endoscopic therapy (see column 4); Cytology brushing or APC to loosen granulation tissue before endoscopic therapy is helpful; If a septum is identified, septotomy must be performed | Surgical approach | Defect < 2 cm: CSDO ± tissue sealants/glues OR tissue sealants/glues ± cap mounted clips OR tissue sealants/glues + intraluminal EVT; -Defect > 2 cm: CSDO ± tissue sealants/glues OR tissue sealants/glues + intraluminal EVT, |
Late and chronic gastro-gastric fistula | Defect < 10 mm: Endoscopic therapy (see column 4); Defect > 10 mm: Surgical approach | Surgical approach after endoscopic management failure | APC ± CSDO ORAPC + suturing OR APC + cap mounted clip |
- Citation: de Oliveira VL, Bestetti AM, Trasolini RP, de Moura EGH, de Moura DTH. Choosing the best endoscopic approach for post-bariatric surgical leaks and fistulas: Basic principles and recommendations. World J Gastroenterol 2023; 29(7): 1173-1193
- URL: https://www.wjgnet.com/1007-9327/full/v29/i7/1173.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i7.1173